Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Regular Articles

Phase I and Pharmacokinetics Study of Crotoxin (Cytotoxic PLA2, NSC-624244) in Patients with Advanced Cancer

Jorge E. Cura, Daniel P. Blanzaco, Cecilia Brisson, Marco A. Cura, Rosa Cabrol, Luis Larrateguy, Carlos Mendez, Jose Carlos Sechi, Jorge Solana Silveira, Elvira Theiller, Adolfo R. de Roodt and Juan Carlos Vidal
Jorge E. Cura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel P. Blanzaco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Brisson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco A. Cura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Cabrol
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis Larrateguy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Mendez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose Carlos Sechi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Solana Silveira
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elvira Theiller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adolfo R. de Roodt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Carlos Vidal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: April 2002 to April 2021

AbstractFull-text HTMLPDF
Total346676673075

Cited By

Article Information

Volume 8, Issue 4, pp. 1033-1041

PubMed 
11948110

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Received March 26, 2001
  • Revision received September 1, 2001
  • Accepted January 9, 2002
  • Published first April 1, 2002.

Copyright & Usage 
© 2002

Author Information

  1. Jorge E. Cura,
  2. Daniel P. Blanzaco,
  3. Cecilia Brisson,
  4. Marco A. Cura,
  5. Rosa Cabrol,
  6. Luis Larrateguy,
  7. Carlos Mendez,
  8. Jose Carlos Sechi,
  9. Jorge Solana Silveira,
  10. Elvira Theiller,
  11. Adolfo R. de Roodt, and
  12. Juan Carlos Vidal2
  1. Department of Medical Oncology Hospital San Martin, Paraná, Entre Rios, Argentina 3100 [J. E. C., D. P. B., C. B., M. A. C., R. C., L. L., C. M., J. C. S., J. S. S., E. T., J. C. V.] and Instituto “Dr. Carlos G. Malbran” Administracion Nacional de Laboratorios e Institutos de Salud, Buenos Aires, Argentina 1281 [A. R. d R.]
View Full Text
PreviousNext
Back to top
April 2002
Volume 8, Issue 4
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Phase I and Pharmacokinetics Study of Crotoxin (Cytotoxic PLA2, NSC-624244) in Patients with Advanced Cancer
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Phase I and Pharmacokinetics Study of Crotoxin (Cytotoxic PLA2, NSC-624244) in Patients with Advanced Cancer
Jorge E. Cura, Daniel P. Blanzaco, Cecilia Brisson, Marco A. Cura, Rosa Cabrol, Luis Larrateguy, Carlos Mendez, Jose Carlos Sechi, Jorge Solana Silveira, Elvira Theiller, Adolfo R. de Roodt and Juan Carlos Vidal
Clin Cancer Res April 1 2002 (8) (4) 1033-1041;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phase I and Pharmacokinetics Study of Crotoxin (Cytotoxic PLA2, NSC-624244) in Patients with Advanced Cancer
Jorge E. Cura, Daniel P. Blanzaco, Cecilia Brisson, Marco A. Cura, Rosa Cabrol, Luis Larrateguy, Carlos Mendez, Jose Carlos Sechi, Jorge Solana Silveira, Elvira Theiller, Adolfo R. de Roodt and Juan Carlos Vidal
Clin Cancer Res April 1 2002 (8) (4) 1033-1041;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Regular Articles

  • Oral Silibinin Inhibits Lung Tumor Growth in Athymic Nude Mice and Forms a Novel Chemocombination with Doxorubicin Targeting Nuclear Factor κB–Mediated Inducible Chemoresistance
  • Antifolate Resistance in a HeLa Cell Line Associated With Impaired Transport Independent of the Reduced Folate Carrier
  • Selective Induction of Apoptosis with Proton Pump Inhibitor in Gastric Cancer Cells
Show more Regular Articles

Clinical Trials

  • Abstract B32: RADIANCE: An open-label, nonrandomized, prospective biomarker study to assess analytic concordance between noninvasive testing and tissue testing for EGFR T790M mutation detection in patients with non-small cell lung cancer
  • Abstract B33: Expansion study of pegylated arginine deiminase (ADI-PEG20), pemetrexed, and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer (TRAP)
  • Abstract B34: Safety and activity of the IL-15/sIL-15Rα complex ALT-803 in combination with the anti-PD1 mAb nivolumab in metastatic non-small cell lung cancer
Show more Clinical Trials
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement